Standardized care may help address the poor outcomes in testicular cancer seen among ethnic minorities and people of low socioeconomic status, according to the findings of a study published in the journal CANCER.
In this study, team led by Aditya Bagrodia, MD, of the University of Texas Southwestern Medical Center in Dallas, examined whether standardized care may help to overcome these barriers and lead to better health outcomes. The researchers analyzed the medical records of patients undergoing treatment for testicular cancer from 2006 to 2018 were analyzed from both the safety net hospital and the academic center. Overall, they assessed 106 patients who received care at the safety net hospital, and 95 who were treated at the academic center. Subsequently, they noted differences between the two groups regarding insurance status, cancer stage at the time of diagnosis, and other factors, but cancer recurrence and mortality rates were similar.
Standardized care may help equalize health outcomes among patients with testicular cancer https://t.co/D66vk72B7e
— Cancer News Network (@cancer_network) August 10, 2020
“Despite stark differences in patient demographics that are usually associated with worse clinical outcomes–including lack of health insurance, delayed presentation, lack of primary care physicians, and minority ethnicity status–we found that standardized care with a multidisciplinary team led to no differences in the way patients were managed and equivalent clinical outcomes,” said Dr. Bagrodia in a press release. “This study illustrates that standardized expert care can overcome factors generally associated with worse clinical outcomes.”
— Wiley Oncology & Hematology (@WileyOnc_Hem) August 10, 2020
— Technology News (@15MinuteNewsTec) August 10, 2020